Skip to main content
. 2021 Sep 1;36(5):369–379. doi: 10.1093/mutage/geab032

Fig. 5.

Fig. 5.

The effect of m6A RNA methylation regulators, the risk score and clinicopathological variables on the prognosis of HCC. (A) Cox univariate analysis of m6A RNA methylation regulators; (B) Partial likelihood deviance versus log (λ) was drawn using LASSO Cox regression model; (C) Coefficients of selected features are shown by lambda parameter. (D) The Kaplan–Meier OS curves for HCC patients assigned to high- and low-risk groups based on the risk score; (E) Time‑dependent risk receiver operating characteristic curves. The 1‑, 3‑ and 5‑year risk AUC were 0.765, 0.722 and 0.619, respectively; (F) The heatmap shows the expression of 5 m6A RNA methylation regulators and the distribution of clinicopathological variables between the high- and low-risk groups (red is upregulated and green is downregulated; *P < 0.05, **P < 0.01); (G) Forest plot of univariate Cox regression analysis in HCC; (H) Forest plot of multivariate Cox regression analysis in HCC.